Month: January 2025

Here’s what really works to relieve post-workout aches—and what doesn’t…Read More

There’s actually a right way to hock a loogie…Read More

What it takes to weigh less by walking…Read More

Whether you’re rooting for the Chiefs (eye roll) or Eagles (gulp), these will prepare you for kick-off…Read More

Berberine is TikTok’s new favorite supplement. But will it actually help you lose weight…Read More

Results of six recent trials of endovascular treatment (EVT) for patients with large-core ischemic stroke (LCIS) provide strong evidence for the benefit of this intervention compared with medical management (MM), a new Science Advisory from the American Heart Association (AHA) has concluded. “These trials provide new data to suggest that selected patients with ischemic stroke […]

Pills can cure infection with the hepatitis C virus (HCV), but getting the medication to patients who need treatment can be a challenge. Many patients with HCV use drugs such as methamphetamine or heroin and were exposed to the virus by sharing needles. Lack of housing…Read More

Two separate clinical trials of dementia care programs report negative results in terms of patient neuropsychiatric symptoms and caregiver strain or distress, but the news may not be all bad. Experts are pointing to the COVID-19 pandemic and the choice of primary outcomes as potential reasons for the null results…Read More

TOPLINE: In a randomized trial, recurrence was higher after superficial curettage (SC) plus imiquimod cream than surgical excision (SE) in patients with nodular basal cell carcinoma (nBCC). METHODOLOGY: In this secondary analysis of the SCIN trial, researchers evaluated 145 patients (53.1% men; median age, 68 years) with histologically confirmed primary nBCC 4-20 mm in size…Read […]

The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes and chronic kidney disease.  The approval is based on the phase 3b results of the international FLOW kidney outcomes trial…Read More